Every podcast, stage, and feature
The complete archive of Sabine Hutchison’s media appearances, speaking engagements, podcast interviews, and press features. Filter by type to find the format you are looking for.

Cut the Chat Life Science InsiderQuality as Culture: Why Biotechs Can’t Afford to Get It Wrong
Quality isn’t just a checkbox — it’s a biotech differentiator. What does “quality” really mean in biotech? And why does it so often get treated…

Cut the Chat Life Science InsiderInnovation, Execution, and Equity in RNA-Based Women’s Health
In this episode, Seuss+ CEO and Co-Founder Sabine Hutchison sits down with Klaas Zuideveld, CEO of Versameb, to discuss the scientific, clinical, and societal implications…

Cut the Chat Life Science InsiderTwo Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)
The Life Science Insider is back with a brand-new video-first format — and this kickoff episode gets real fast. In this raw, unscripted premiere, Seuss+…


NVFG biotech day 2.0NVFG biotech day 2.0
Connecting biotech founders with investors and practical industry solutions

Cut the Chat Life Science InsiderAI in Biotech: Hype, Reality, and the Future of Drug Development
In this episode, Christina Busmalis and Sabine dive deep into the evolving intersection of AI and drug development. They explore the challenges and opportunities posed…

Cut the Chat Life Science insiderAI in Biotech: Hype, Reality, and the Future of Drug Development
In this episode, Christina Busmalis and Sabine dive deep into the evolving intersection of AI and drug development. They explore the challenges and opportunities posed…

Cut the Chat Life Science InsiderTransforming Clinical Trials: How Digital Endpoints Are Leading the Way
We explore the transformative potential of digital endpoints in clinical trials, emphasizing their role in revolutionizing data collection for patients, regulators, and payers.

Cut the Chat Life Science InsiderNavigating the Commercialization Journey: Insights from Science to Market
In the second episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the dynamic Kirsten Detrick, whose extensive experience in…

Cut the Chat Life Science InsiderBridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
Sabine Hutchison talks to the inspiring investor Stephanie Oestreich. In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined…

J.P Morgan healthcare conferenceJ.P Morgan healthcare conference
How to flex our conversational muscles and break inertia

Cut the Chat Life Science InsiderMastering the Art of Collaboration: Principal Investigator and Biotech Dynamics
Sabine Hutchison sits down with the incredible Viviënne van de Walle a highly respected principal investigator who brings her wealth of experience to the table,…

Cut the Chat Life Science InsiderCross-Pollination and DEI Strategies with Ben Osborn
In Episode 4 of "Cut the Chat," host Sabine Hutchison engages in a thought-provoking discussion with Ben Osborn, a prominent figure in the biopharma industry…

Cut the Chat Life Science InsiderCracking the code: Navigating the Ever-Changing Biotech Landscape
Join Seuss+ CEO and Co-Founder Sabine Hutchison as she sits down with the accomplished Dr. Allison Jeynes-Ellis, a visionary leader whose journey spans medicine, oncology,…

Cut the Chat Life Science InsiderInnovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
Seuss+ CEO and Co-Founder Sabine Hutchison delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the competitive Biotech…

Cut the Chat Life Science InsiderEpisode 1: Smart KPIs for Biotechs
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits…

HBA European Leadership SummitHBA European Leadership Summit
Supporting global development of small to mid sized biotech companies




HBA Annual ConferenceHBA Annual Conference
Translating Talk into Action: How organizations nurture and stimulate greater diversity



Webinar: RFP to Reality: Vendor Selections in Drug Development
Seuss+ CEOs Kieran Canisius and Sabine Hutchison lead a fireside chat uncovering critical lessons from over a decade of vendor selections in drug development. The…

Webinar: Navigate Vendor Management in Life Sciences: From Compliance to Collaboration
This exclusive webinar features CEO Sabine Hutchison and Senior Business Consultant Nicolyn Liebenberg as they unpack the complexities of managing vendor relationships within stringent regulatory…
What this archive contains
This page lists every publicly available media appearance by Sabine Hutchison, Co-CEO and Co-Founder of Seuss+. Each card links to the original source where possible: the podcast episode, the conference page, the published article, or the recording. Use the filter buttons above to narrow by format. Sabine has spent over two decades inside clinical development as a scientist, data leader, and governance advisor, and this archive is the full record of how she has framed that work for public audiences.
How to use this archive
- Filter by format using the buttons above the grid. Podcasts, speaking, press, and articles each have their own button.
- Every card links to the original source where available. Broken or removed links redirect to the media request page.
- New appearances are added within two weeks of publication. Expect roughly one to three new items per month.
- For interviews and research, press contacts are listed on the media page, not here.
- To book Sabine for your own show or stage, use the media booking form rather than contacting sources directly.
Formats Sabine appears in
Sabine accepts appearances across four formats, each with a different editorial approach. Podcasts are her most frequent format, typically 45 to 60 minute conversations on clinical governance, vendor-sponsor trust, and leadership under operational pressure. Conference stages include keynotes and panels at biotech, pharma, and clinical operations events, usually tied to a specific governance or partnership theme. Press features cover written interviews, contributed commentary, and quoted sources in longer-form industry journalism. Published articles are pieces she has authored for external publications, distinct from the essays she writes on her own Insights page.
The format changes, but the argument stays the same. Clinical trials don't fail at the site. They fail at the partnership.
Topics Sabine speaks on
Across every format, her topics cluster around four themes: vendor selection as a leadership decision, not a procurement exercise; governance as an oversight architecture, distinct from status reporting; data ownership as trust infrastructure, embedded in contracts rather than negotiated during a crisis; and partnership integrity as a leading indicator of clinical program outcomes. Producers and journalists working on any of these angles will find a coherent point of view across this archive. For the written arguments, see her recent perspectives. For her full background, see the about page.
The industry backdrop
Booking and editorial standards
Sabine accepts a limited number of appearances each year and is selective about fit. She prefers formats that let her defend a position rather than hedge, and audiences that are either practitioners inside clinical development or decision-makers whose choices shape it. She does not accept appearances that require her to pitch products, validate preselected narratives, or speak outside her operating expertise. Requests go through the media booking form, which routes to her assistant and returns a yes or no within two business days, including proposed angles and available dates.
Frequently asked questions about appearances
Standard speaking honorariums for paid engagements are accepted. Podcast interviews and editorial press features are typically unpaid, per industry norms. Travel and accommodation are covered by the inviting party for in-person engagements outside Hamburg, Germany.
English is the default for both recorded and live appearances. German is available on request for German-speaking audiences, with advance notice.
For podcasts: two to four weeks. For conference keynotes: six to twelve weeks. For press interviews tied to a news cycle: forty-eight to seventy-two hours is workable with flexible scheduling.
Yes for press features, where fact-checking benefits both sides. No for podcast conversations or live panels, which she prefers to enter without rehearsed answers.
All requests go through the media booking form. Direct outreach to Seuss+ or personal email delays response rather than speeding it up.




